News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medicis Licenses SubQ From Q-Med AB


10/19/2005 5:09:01 PM

Medicis (NYSE:MRX) today announced that it has entered into an exclusive license agreement with Q-Med AB ("Q-Med") to market, distribute, sell and commercialize in the United States and Canada Q-Med's product currently known as SubQ(TM). Q-Med will have the exclusive right to manufacture SubQ(TM) for Medicis. SubQ(TM) is not approved currently for use in the United States and Canada.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES